Turner Heather D 4
4 · Atara Biotherapeutics, Inc. · Filed Feb 12, 2018
Insider Transaction Report
Form 4
Turner Heather D
VP, General Counsel & Sec.
Transactions
- Sale
Common Stock
2018-02-09$38.63/sh−600$23,178→ 72,389 total - Sale
Common Stock
2018-02-09$39.66/sh−733$29,071→ 71,656 total - Sale
Common Stock
2018-02-09$36.63/sh−4,596$168,351→ 77,112 total - Sale
Common Stock
2018-02-09$37.38/sh−4,123$154,118→ 72,989 total - Sale
Common Stock
2018-02-09$40.62/sh−600$24,372→ 71,056 total - Sale
Common Stock
2018-02-09$41.69/sh−1,562$65,120→ 69,494 total
Footnotes (7)
- [F1]Transaction pursuant to Rule 10b5-1 Plan adopted September 23, 2016.
- [F2]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $36.00 to $37.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $37.05 to $38.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $38.10 to $39.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $39.15 to $39.95. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $40.20 to $41.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.35 to $41.80. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.